The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 37; no. 12; pp. 2336 - 2341
Main Authors Krismer, Florian, Palma, Jose‐Alberto, Calandra‐Buonaura, Giovanna, Stankovic, Iva, Vignatelli, Luca, Berger, Anna‐Karin, Falup‐Pecurariu, Cristian, Foubert‐Samier, Alexandra, Höglinger, Günter, Kaufmann, Horacio, Kellerman, Larry, Kim, Han‐Joon, Klockgether, Thomas, Levin, Johannes, Martinez‐Martin, Pablo, Mestre, Tiago A., Pellecchia, Maria Teresa, Perlman, Susan, Qureshi, Irfan, Rascol, Olivier, Schrag, Anette, Seppi, Klaus, Shang, Huifang, Stebbins, Glenn T., Wenning, Gregor K., Singer, Wolfgang, Meissner, Wassilios G.
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.12.2022
Wiley Subscription Services, Inc
Wiley
Subjects
Atrophy
Disability Evaluation
Humans
Life Sciences
Movement disorders
Multiple System Atrophy - diagnosis
Santé publique et épidémiologie
Severity of Illness Index
Viewpoint
Online AccessGet full text

Cover

Author Krismer, Florian
Meissner, Wassilios G.
Qureshi, Irfan
Kellerman, Larry
Klockgether, Thomas
Singer, Wolfgang
Calandra‐Buonaura, Giovanna
Höglinger, Günter
Seppi, Klaus
Schrag, Anette
Foubert‐Samier, Alexandra
Wenning, Gregor K.
Berger, Anna‐Karin
Falup‐Pecurariu, Cristian
Stankovic, Iva
Perlman, Susan
Martinez‐Martin, Pablo
Kaufmann, Horacio
Levin, Johannes
Kim, Han‐Joon
Pellecchia, Maria Teresa
Mestre, Tiago A.
Vignatelli, Luca
Palma, Jose‐Alberto
Rascol, Olivier
Stebbins, Glenn T.
Shang, Huifang
AuthorAffiliation 21 Department of Neurology David Geffen School of Medicine at UCLA Los Angeles California USA
26 Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA
22 Pharmaceutical Company Biohaven Pharmaceuticals New Haven Connecticut USA
3 Dipartimento di Scienze Biomediche e Neuromotorie Università di Bologna Bologna Italy
19 Parkinson's Disease and Movement Disorders Center, Division of Neurology, Department of Medicine The Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Institute Ottawa Ontario Canada
11 Patient Advocacy Group Multiple System Atrophy Coalition McLean Virginia USA
14 German Center for Neurodegenerative Diseases (DZNE) Bonn Germany
4 IRCCS, Istituto delle Scienze Neurologiche di Bologna Bologna Italy
23 French Reference Center for MSA, CIC 1436, NS‐Park/FCRIN network and NeuroToul COEN Center University Hospital of Toulouse, University of Toulouse 3 and INSERM Toulouse France
7 Department of Neurology, County Clinic Hospital, Fac
AuthorAffiliation_xml – name: 9 German Center for Neurodegenerative Diseases (DZNE) Munich Germany
– name: 5 Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine University of Belgrade Beograd Serbia
– name: 6 Clinical Science, Assessment and Innovation, Department of Clinical Development Lundbeck Valby Denmark
– name: 4 IRCCS, Istituto delle Scienze Neurologiche di Bologna Bologna Italy
– name: 10 Department of Neurology Hannover Medical School Hannover Germany
– name: 1 Department of Neurology Medical University Innsbruck Innsbruck Austria
– name: 14 German Center for Neurodegenerative Diseases (DZNE) Bonn Germany
– name: 8 CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc Bordeaux France
– name: 21 Department of Neurology David Geffen School of Medicine at UCLA Los Angeles California USA
– name: 25 Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center West China Hospital, Sichuan University Chengdu China
– name: 26 Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA
– name: 13 Department of Neurology University Hospital Bonn Bonn Germany
– name: 3 Dipartimento di Scienze Biomediche e Neuromotorie Università di Bologna Bologna Italy
– name: 11 Patient Advocacy Group Multiple System Atrophy Coalition McLean Virginia USA
– name: 19 Parkinson's Disease and Movement Disorders Center, Division of Neurology, Department of Medicine The Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Institute Ottawa Ontario Canada
– name: 2 Department of Neurology New York University Grossman School of Medicine New York New York USA
– name: 27 Department of Neurology Mayo Clinic Rochester Minnesota USA
– name: 30 New Zealand Brain Research Institute Christchurch New Zealand
– name: 24 Department of Clinical Neurosciences, UCL Queen Square Institute of Neurology University College London London United Kingdom
– name: 22 Pharmaceutical Company Biohaven Pharmaceuticals New Haven Connecticut USA
– name: 28 University of Bordeaux, CNRS, IMN, UMR 5293 Bordeaux France
– name: 7 Department of Neurology, County Clinic Hospital, Faculty of Medicine Transylvania University Brasov Romania
– name: 15 Department of Neurology Ludwig‐Maximilians‐Universität München Munich Germany
– name: 17 SME MODAG GmbH Wendelsheim Germany
– name: 12 Department of Neurology and Movement Disorder Center Seoul National University Hospital Seoul South Korea
– name: 16 Munich Cluster for Systems Neurology (SyNergy) Munich Germany
– name: 18 Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) Carlos III Institute of Health Madrid Spain
– name: 29 Department of Medicine University of Otago Christchurch New Zealand
– name: 20 Department of Medicine, Surgery and Dentistry, Neuroscience Section University of Salerno Salerno Italy
– name: 23 French Reference Center for MSA, CIC 1436, NS‐Park/FCRIN network and NeuroToul COEN Center University Hospital of Toulouse, University of Toulouse 3 and INSERM Toulouse France
Author_xml – sequence: 1
  givenname: Florian
  orcidid: 0000-0002-4493-5073
  surname: Krismer
  fullname: Krismer, Florian
  organization: Medical University Innsbruck
– sequence: 2
  givenname: Jose‐Alberto
  surname: Palma
  fullname: Palma, Jose‐Alberto
  organization: New York University Grossman School of Medicine
– sequence: 3
  givenname: Giovanna
  surname: Calandra‐Buonaura
  fullname: Calandra‐Buonaura, Giovanna
  organization: IRCCS, Istituto delle Scienze Neurologiche di Bologna
– sequence: 4
  givenname: Iva
  orcidid: 0000-0003-1484-4717
  surname: Stankovic
  fullname: Stankovic, Iva
  organization: University of Belgrade
– sequence: 5
  givenname: Luca
  orcidid: 0000-0002-9051-7091
  surname: Vignatelli
  fullname: Vignatelli, Luca
  organization: IRCCS, Istituto delle Scienze Neurologiche di Bologna
– sequence: 6
  givenname: Anna‐Karin
  surname: Berger
  fullname: Berger, Anna‐Karin
  organization: Lundbeck
– sequence: 7
  givenname: Cristian
  surname: Falup‐Pecurariu
  fullname: Falup‐Pecurariu, Cristian
  organization: Transylvania University
– sequence: 8
  givenname: Alexandra
  surname: Foubert‐Samier
  fullname: Foubert‐Samier, Alexandra
  organization: CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc
– sequence: 9
  givenname: Günter
  orcidid: 0000-0001-7587-6187
  surname: Höglinger
  fullname: Höglinger, Günter
  organization: Hannover Medical School
– sequence: 10
  givenname: Horacio
  surname: Kaufmann
  fullname: Kaufmann, Horacio
  organization: New York University Grossman School of Medicine
– sequence: 11
  givenname: Larry
  surname: Kellerman
  fullname: Kellerman, Larry
  organization: Multiple System Atrophy Coalition
– sequence: 12
  givenname: Han‐Joon
  orcidid: 0000-0001-8219-9663
  surname: Kim
  fullname: Kim, Han‐Joon
  organization: Seoul National University Hospital
– sequence: 13
  givenname: Thomas
  orcidid: 0000-0001-6174-5442
  surname: Klockgether
  fullname: Klockgether, Thomas
  organization: German Center for Neurodegenerative Diseases (DZNE)
– sequence: 14
  givenname: Johannes
  surname: Levin
  fullname: Levin, Johannes
  organization: MODAG GmbH
– sequence: 15
  givenname: Pablo
  surname: Martinez‐Martin
  fullname: Martinez‐Martin, Pablo
  organization: Carlos III Institute of Health
– sequence: 16
  givenname: Tiago A.
  orcidid: 0000-0002-6973-7479
  surname: Mestre
  fullname: Mestre, Tiago A.
  organization: The Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Institute
– sequence: 17
  givenname: Maria Teresa
  orcidid: 0000-0002-6217-313X
  surname: Pellecchia
  fullname: Pellecchia, Maria Teresa
  organization: University of Salerno
– sequence: 18
  givenname: Susan
  surname: Perlman
  fullname: Perlman, Susan
  organization: David Geffen School of Medicine at UCLA
– sequence: 19
  givenname: Irfan
  surname: Qureshi
  fullname: Qureshi, Irfan
  organization: Biohaven Pharmaceuticals
– sequence: 20
  givenname: Olivier
  orcidid: 0000-0002-1410-6397
  surname: Rascol
  fullname: Rascol, Olivier
  organization: University Hospital of Toulouse, University of Toulouse 3 and INSERM
– sequence: 21
  givenname: Anette
  orcidid: 0000-0002-9872-6680
  surname: Schrag
  fullname: Schrag, Anette
  organization: University College London
– sequence: 22
  givenname: Klaus
  orcidid: 0000-0001-6503-1455
  surname: Seppi
  fullname: Seppi, Klaus
  organization: Medical University Innsbruck
– sequence: 23
  givenname: Huifang
  surname: Shang
  fullname: Shang, Huifang
  organization: West China Hospital, Sichuan University
– sequence: 24
  givenname: Glenn T.
  surname: Stebbins
  fullname: Stebbins, Glenn T.
  organization: Rush University Medical Center
– sequence: 25
  givenname: Gregor K.
  surname: Wenning
  fullname: Wenning, Gregor K.
  organization: Medical University Innsbruck
– sequence: 26
  givenname: Wolfgang
  surname: Singer
  fullname: Singer, Wolfgang
  organization: Mayo Clinic
– sequence: 27
  givenname: Wassilios G.
  orcidid: 0000-0003-2172-7527
  surname: Meissner
  fullname: Meissner, Wassilios G.
  email: wassilios.meissner@chu-bordeaux.fr
  organization: New Zealand Brain Research Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36074648$$D View this record in MEDLINE/PubMed
https://hal.science/hal-03835333$$DView record in HAL
BookMark eNp1kV1LHDEUhkOx1NX2on-gBHpjwdF8TjK9EJbV1sJKwVV6GbKTM25kJtlOZiz7742uta3Qq0Dy5Hlz8u6hnRADIPSekiNKCDvuXDpiFaPyFZpQyWmhmVQ7aEK0lgWnWu6ivZRuCaFU0vIN2uUlUaIUeoJ-XK0AXwffeHD4YmwHv24BLzZpgA5Phz6uVxt8aQcfbvCiti18xovBDmM6xLPeD_7nCIfYBocvoY5dB8FlNob0Fr1ubJvg3dO6j66_nF3Nzov596_fZtN5UQulZGFVU-mKWQHMEVcpZQVnEiRxvG5EVRJwS8GAVctlqUhpqWPOUuUoBaU1qfg-Otl61-OyA1dDGHrbmnXvO9tvTLTe_HsS_MrcxDuTs6guyyz4tBWsXlw7n87Nwx7hmkvO-R3N7MFTWB_z4GkwnU81tK0NEMdkmKJUC1ExntGPL9DbOPYhf0WmpBRaior8Ca_7mFIPzfMLKDEP1ZpcrXmsNrMf_p70mfzdZQaOt8Av38Lm_yZzcbrYKu8BntyuLA
CitedBy_id crossref_primary_10_1007_s10286_023_00934_0
crossref_primary_10_1007_s10286_023_00974_6
crossref_primary_10_1007_s11910_024_01335_0
crossref_primary_10_3389_fneur_2023_1210220
crossref_primary_10_1111_cns_14341
crossref_primary_10_1186_s12916_022_02645_1
crossref_primary_10_1038_s41598_024_55862_4
crossref_primary_10_3390_brainsci14020181
crossref_primary_10_3389_fneur_2022_1081219
crossref_primary_10_1002_mdc3_13734
crossref_primary_10_1016_j_heliyon_2024_e26479
Cites_doi 10.1002/mds.28923
10.1016/S1474-4422(14)70288-1
10.1016/j.jclinepi.2010.02.006
10.1016/j.parkreldis.2021.11.024
10.1002/mds.20450
10.1002/mds.27080
10.1002/mds.10290
10.1016/S1474-4422(15)00058-7
10.1007/s13760-018-0962-4
10.1002/mds.28218
10.1016/S1474-4422(13)70301-6
10.1002/mds.28993
10.1212/WNL.0000000000007720
10.1007/s10286-021-00782-w
10.1002/mds.21649
10.1002/mds.20255
10.1016/S1474-4422(12)70327-7
10.1016/j.nbd.2020.104813
10.1016/S1474-4422(19)30141-3
10.1002/mds.25174
10.1002/mds.28067
10.1002/mds.10171
10.1002/mds.25181
10.1111/ncn3.12477
10.1002/mds.20808
ContentType Journal Article
Copyright 2022 The Authors. published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society
2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Attribution
Copyright_xml – notice: 2022 The Authors. published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society
– notice: 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Attribution
DBID 24P
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
1XC
VOOES
5PM
DOI 10.1002/mds.29215
DatabaseName Wiley Online Library
Wiley Online Library
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Nursing & Allied Health Premium
Genetics Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley-Blackwell Open Access Collection
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate CRITIQUE ON UMSARS
EISSN 1531-8257
EndPage 2341
ExternalDocumentID oai_HAL_hal_03835333v1
10_1002_mds_29215
36074648
MDS29215
Genre commentary
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: R01 NS092625
– fundername: NINDS NIH HHS
  grantid: R01 NS107596
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1CY
1L6
1OB
1OC
1ZS
24P
31~
33P
3PY
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
FYBCS
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6M
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWD
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
YCJ
ZGI
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
1XC
VOOES
5PM
ID FETCH-LOGICAL-c4775-a7f9892a4e2d0d977a4325e50d3cf4960edb42e29bb6706a1d2da17d11e788093
IEDL.DBID 24P
ISSN 0885-3185
IngestDate Tue Sep 17 21:33:00 EDT 2024
Fri Sep 06 12:48:52 EDT 2024
Fri Aug 16 09:27:14 EDT 2024
Fri Sep 13 04:08:40 EDT 2024
Fri Aug 23 03:27:45 EDT 2024
Sat Sep 28 08:12:53 EDT 2024
Sat Aug 24 00:59:52 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License Attribution
Attribution: http://creativecommons.org/licenses/by
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4775-a7f9892a4e2d0d977a4325e50d3cf4960edb42e29bb6706a1d2da17d11e788093
Notes Full financial disclosures and author roles may be found in the online version of this article.
Nothing to report.
Florian Krismer, Jose‐Alberto Palma, Wolfgang Singer, and Wassilios G. Meissner contributed equally to this work.
Relevant conflicts of interest/financial disclosures
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Relevant conflicts of interest/financial disclosures: Nothing to report.
ORCID 0000-0003-1484-4717
0000-0002-6217-313X
0000-0001-8219-9663
0000-0002-9051-7091
0000-0001-6503-1455
0000-0001-7587-6187
0000-0001-6174-5442
0000-0002-9872-6680
0000-0003-2172-7527
0000-0002-1410-6397
0000-0002-6973-7479
0000-0002-4493-5073
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.29215
PMID 36074648
PQID 2755485490
PQPubID 1016421
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9771866
hal_primary_oai_HAL_hal_03835333v1
proquest_miscellaneous_2711844923
proquest_journals_2755485490
crossref_primary_10_1002_mds_29215
pubmed_primary_36074648
wiley_primary_10_1002_mds_29215_MDS29215
PublicationCentury 2000
PublicationDate December 2022
PublicationDateYYYYMMDD 2022-12-01
PublicationDate_xml – month: 12
  year: 2022
  text: December 2022
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Hoboken
PublicationTitle Movement disorders
PublicationTitleAlternate Mov Disord
PublicationYear 2022
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
– name: Wiley
References 2021; 9
2002; 17
2015; 14
2019; 93
2021; 31
2004; 19
2022
2022; 94
2006; 21
2013; 12
2018; 118
2017; 32
2020; 139
2005; 20
2014; 13
2019; 18
2022; 37
2020; 35
2012; 27
2007; 22
2010; 63
e_1_2_11_10_1
e_1_2_11_14_1
e_1_2_11_13_1
e_1_2_11_12_1
e_1_2_11_11_1
e_1_2_11_7_1
e_1_2_11_6_1
e_1_2_11_5_1
e_1_2_11_4_1
e_1_2_11_26_1
e_1_2_11_3_1
e_1_2_11_2_1
e_1_2_11_21_1
e_1_2_11_20_1
e_1_2_11_25_1
e_1_2_11_24_1
e_1_2_11_9_1
e_1_2_11_23_1
e_1_2_11_8_1
e_1_2_11_22_1
e_1_2_11_18_1
e_1_2_11_17_1
e_1_2_11_16_1
e_1_2_11_15_1
e_1_2_11_19_1
References_xml – volume: 37
  year: 2022
  article-title: mTOR inhibition with Sirolimus in multiple system atrophy: a randomized, double‐blind, placebo‐controlled futility trial and 1‐year biomarker longitudinal analysis
  publication-title: Mov Disord
– volume: 17
  start-page: 1248
  issue: 6
  year: 2002
  end-page: 1254
  article-title: Application of the international cooperative ataxia scale rating in multiple system atrophy
  publication-title: Mov Disord
– volume: 94
  start-page: 40
  year: 2022
  end-page: 44
  article-title: An item response theory analysis of the unified multiple system atrophy rating scale
  publication-title: Parkinsonism Relat Disord
– volume: 93
  start-page: e77
  issue: 1
  year: 2019
  end-page: e87
  article-title: Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy
  publication-title: Neurology
– volume: 9
  start-page: 171
  issue: 2
  year: 2021
  end-page: 180
  article-title: Reliability and validity of Japanese version of unified multiple system atrophy rating scale
  publication-title: Neurol Clin Neurosci
– volume: 63
  start-page: 737
  issue: 7
  year: 2010
  end-page: 745
  article-title: The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health‐related patient‐reported outcomes
  publication-title: J Clin Epidemiol
– volume: 22
  start-page: 2332
  issue: 16
  year: 2007
  end-page: 2338
  article-title: Measuring health‐related quality of life in MSA: the MSA‐QoL
  publication-title: Mov Disord
– volume: 12
  start-page: 264
  issue: 3
  year: 2013
  end-page: 274
  article-title: The natural history of multiple system atrophy: a prospective European cohort study
  publication-title: Lancet Neurol
– volume: 139
  year: 2020
  article-title: Disease progression and prognostic factors in multiple system atrophy: a prospective cohort study
  publication-title: Neurobiol Dis
– volume: 17
  start-page: 701
  issue: 4
  year: 2002
  end-page: 709
  article-title: Parkinsonism in multiple system atrophy: natural history, severity (UPDRS‐III), and disability assessment compared with Parkinson's disease
  publication-title: Mov Disord
– volume: 27
  start-page: 1574
  issue: 12
  year: 2012
  end-page: 1577
  article-title: Assessment of quality of life with the multiple system atrophy health‐related quality of life scale
  publication-title: Mov Disord
– volume: 32
  start-page: 1356
  issue: 10
  year: 2017
  end-page: 1364
  article-title: Critical appraisal of clinical trials in multiple system atrophy: toward better quality
  publication-title: Mov Disord
– volume: 19
  start-page: 1391
  issue: 12
  year: 2004
  end-page: 1402
  article-title: Development and validation of the unified multiple system atrophy rating scale (UMSARS)
  publication-title: Mov Disord
– volume: 31
  start-page: 157
  issue: 2
  year: 2021
  end-page: 164
  article-title: Limitations of the unified multiple system atrophy rating scale as outcome measure for clinical trials and a roadmap for improvement
  publication-title: Clin Auton Res
– volume: 27
  start-page: 1683
  issue: 13
  year: 2012
  end-page: 1685
  article-title: The unified multiple system atrophy rating scale: intrarater reliability
  publication-title: Mov Disord
– volume: 13
  start-page: 268
  issue: 3
  year: 2014
  end-page: 275
  article-title: Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double‐blind, placebo‐controlled trial
  publication-title: Lancet Neurol
– volume: 35
  start-page: 711
  issue: 5
  year: 2020
  end-page: 715
  article-title: Impact of the COVID‐19 pandemic on Parkinson's disease and movement disorders
  publication-title: Mov Disord
– volume: 18
  start-page: 724
  issue: 8
  year: 2019
  end-page: 735
  article-title: Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double‐blind, placebo‐controlled trial
  publication-title: Lancet Neurol
– volume: 14
  start-page: 145
  issue: 2
  year: 2015
  end-page: 152
  article-title: Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo‐controlled trial
  publication-title: Lancet Neurol
– volume: 21
  start-page: 809
  issue: 6
  year: 2006
  end-page: 815
  article-title: Health‐related quality of life in multiple system atrophy
  publication-title: Mov Disord
– volume: 118
  start-page: 589
  issue: 4
  year: 2018
  end-page: 595
  article-title: Factors associated with deterioration of health‐related quality of life in multiple system atrophy: 1‐year follow‐up study
  publication-title: Acta Neurol Belg
– volume: 35
  start-page: 1957
  issue: 11
  year: 2020
  end-page: 1965
  article-title: A phase 1 randomized trial of specific active alpha‐Synuclein immunotherapies PD01A and PD03A in multiple system atrophy
  publication-title: Mov Disord
– volume: 20
  start-page: 951
  issue: 8
  year: 2005
  end-page: 957
  article-title: Depressive symptoms and life satisfaction in patients with multiple system atrophy
  publication-title: Mov Disord
– year: 2022
  article-title: Sensitivity to change and patient‐centricity of the unified multiple system atrophy rating scale items: a data‐driven analysis
  publication-title: Mov Disord
– volume: 14
  start-page: 710
  issue: 7
  year: 2015
  end-page: 719
  article-title: Natural history of multiple system atrophy in the USA: a prospective cohort study
  publication-title: Lancet Neurol
– ident: e_1_2_11_13_1
  doi: 10.1002/mds.28923
– ident: e_1_2_11_7_1
  doi: 10.1016/S1474-4422(14)70288-1
– ident: e_1_2_11_26_1
  doi: 10.1016/j.jclinepi.2010.02.006
– ident: e_1_2_11_18_1
  doi: 10.1016/j.parkreldis.2021.11.024
– ident: e_1_2_11_21_1
  doi: 10.1002/mds.20450
– ident: e_1_2_11_8_1
  doi: 10.1002/mds.27080
– ident: e_1_2_11_15_1
  doi: 10.1002/mds.10290
– ident: e_1_2_11_6_1
  doi: 10.1016/S1474-4422(15)00058-7
– ident: e_1_2_11_19_1
  doi: 10.1007/s13760-018-0962-4
– ident: e_1_2_11_12_1
  doi: 10.1002/mds.28218
– ident: e_1_2_11_5_1
  doi: 10.1016/S1474-4422(13)70301-6
– ident: e_1_2_11_20_1
  doi: 10.1002/mds.28993
– ident: e_1_2_11_9_1
  doi: 10.1212/WNL.0000000000007720
– ident: e_1_2_11_17_1
  doi: 10.1007/s10286-021-00782-w
– ident: e_1_2_11_25_1
  doi: 10.1002/mds.21649
– ident: e_1_2_11_2_1
  doi: 10.1002/mds.20255
– ident: e_1_2_11_4_1
  doi: 10.1016/S1474-4422(12)70327-7
– ident: e_1_2_11_11_1
  doi: 10.1016/j.nbd.2020.104813
– ident: e_1_2_11_10_1
  doi: 10.1016/S1474-4422(19)30141-3
– ident: e_1_2_11_23_1
  doi: 10.1002/mds.25174
– ident: e_1_2_11_24_1
  doi: 10.1002/mds.28067
– ident: e_1_2_11_14_1
  doi: 10.1002/mds.10171
– ident: e_1_2_11_3_1
  doi: 10.1002/mds.25181
– ident: e_1_2_11_16_1
  doi: 10.1111/ncn3.12477
– ident: e_1_2_11_22_1
  doi: 10.1002/mds.20808
SSID ssj0011516
Score 2.5077596
SourceID pubmedcentral
hal
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2336
SubjectTerms Atrophy
Disability Evaluation
Humans
Life Sciences
Movement disorders
Multiple System Atrophy - diagnosis
Santé publique et épidémiologie
Severity of Illness Index
Viewpoint
Title The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.29215
https://www.ncbi.nlm.nih.gov/pubmed/36074648
https://www.proquest.com/docview/2755485490/abstract/
https://search.proquest.com/docview/2711844923
https://hal.science/hal-03835333
https://pubmed.ncbi.nlm.nih.gov/PMC9771866
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB5RKqFeELRQwqNyUQ8cCDi2EydwWpWiVcVWFQ_BLbLXE8Fhs4jd5fczdrKBFarUS5TEjuLMeDzfxOPPAD84ZuS3cxsbsqSYRslhbK2kS4ukbVSYucD2-Sfr36jfd-ndEpzO18I0_BDdDzdvGWG89gZu7OT4lTR05CZHohB-gflHgjW579JC_e2mEMiVZQ2ETMMS4TmtEBfH3aMLzujDvU-FfI8z36dLvoWxwQ-dr8FqCyBZr9H4Oixh_RlWBu0U-Re4JcUzQpIVYUs2aNMFWUNMznrTpzHJlV0an-3MrkhBeMI84JxNDlnY9oBadchM7ZgPTEcjbDddmmzAzfmv65_9uN09IR4qrdPY6KrIC2EUCscdwTyjpEgx5U4OK0WBCzqrBIrC2kzzzCROOJNolyRIYTEv5CYs1-Mat4Dx1BAOlEJXiKpS2soEK1MpoYdVkaYygv25GMvHhiSjbOiQRUmyLoOsqRIJuCv3tNb93kXp73EKkwl2yuckgt25_MvWmOhxTZgnp0CWR_C9KyYz8HMbpsbxzNehSEl5trkIvjbq6l4lM7-pisoj0AuKXGjLYkn9cB-otklsnhEwgoOg8n9_XTk4uwon2_9fdQc-Cb-YIiTH7MLy9GmGewRxpvZb6Mp0PLsUL9pa9ss
link.rule.ids 230,315,786,790,891,1382,11589,27957,27958,46087,46329,46511,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwED6NIQEviN8ENjCIBx6WzbGduJn2UgFTgXZCbBN7i-z6ovHQFK3t_n7unDRQTUi8JbGtOHc5-zv7_B3AO4kFzdsDnzqypJRGyWnqvaZbj6RtNFiEyPZ5UozOzZeL_GILjtZnYVp-iH7BjS0jjtds4LwgffCHNXQWFvuqVHzC_DZn9GazVOZbv4dAc1nRYsg8nhFe8wpJddA33ZiNbl1yLORNoHkzXvJvHBsnouMHcL9DkGLYqvwhbGHzCO5Muj3yx_CDNC8IStYELsWkixcULTO5GC6v5iRY8d1xuLM4JQ3hoWDEuVrsiZj3gHq1J1wTBHumsxl2WZcWT-D8-NPZh1HapU9Ip8baPHW2LgelcgZVkIFwnjNa5ZjLoKe1Ic8FgzcKVel9YWXhsqCCy2zIMiS_WJb6KWw38wafg5C5IyCola0RTW2s1xnWrjbKTusyz3UCb9dirH61LBlVy4esKpJ1FWVNlUjAfTnzWo-G44qfSfKTCXfq6yyBnbX8q86aqLkl0DMgT1Ym8KYvJjvgzQ3X4HzFdchVMkw3l8CzVl39q3TBWVXMIAG7ociNvmyWND8vI9c2iY0pARN4H1X-76-rJh9P48WL_6_6Gu6Ozibjavz55OtLuKf4ZEWMlNmB7eXVCncJ7yz9q_hb_wY9uflD
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVceD8CBQziwKHZOrYTb-C0Ylkt0K1QS0UPSJEdT1SENlt1dznw6xk7D1gqJMQtiW0l9szY38TjbwBecMxo3R7a2JAlxTRLlrG1km4tkrRRYeYC2-dhNj1R70_T0y143Z2Fafgh-h9u3jLCfO0N_NxV-79IQ-duORC58AfMr6pMCq_S46OeO4qQTsh7SlaUhiPCHa0QF_t9043F6MqZD4W8jDMvh0v-DmPDOjS5AV-6HjThJ98G65UdlD_-IHf8zy7ehOstPmWjRqFuwRbWt2Fn1u7A34HPpFeMgGpF0JXN2mhE1vCes9HqYkFiY0fGB1OzY5I_vmIez66XeyxkVaBO7zFTO-b93vkc25xOy7twMnn76c00bpMzxKXSOo2NrvJhLoxC4bgjFGmUFCmm3MmyUuQXobNKoMitzTTPTOKEM4l2SYLkdfNc3oPtelHjA2A8NQQzpdAVoqqUtjLBylRK6LLK01RG8LyTUnHecHAUDduyKGiIijBEVInk15d71uzp6KDwzzh54YRq5fckgt1OvEVrq9RcE6Qakp_MI3jWF5OV-a0TU-Ni7euQI6Y8mV0E9xtt6F8lM5-zRQ0j0Bt6svEtmyX117PA5E3D5gkHI3gZ1ODvvStm4-Nw8fDfqz6FnY_jSXHw7vDDI7gm_LGNEIazC9urizU-JjC1sk-C0fwEuAUYxQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Unified+Multiple+System+Atrophy+Rating+Scale%3A+Status%2C+Critique%2C+and+Recommendations&rft.jtitle=Movement+disorders&rft.au=Krismer%2C+Florian&rft.au=Palma%2C+Jose-Alberto&rft.au=Calandra-Buonaura%2C+Giovanna&rft.au=Stankovic%2C+Iva&rft.date=2022-12-01&rft.pub=Wiley&rft.issn=0885-3185&rft.eissn=1531-8257&rft.volume=37&rft.issue=12&rft.spage=2336&rft.epage=2341&rft_id=info:doi/10.1002%2Fmds.29215&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai_HAL_hal_03835333v1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon